While Olive et al. demonstrated that anti-HVEM antibodies can suppress tumor metastasis by activating T-cell mediated immunity in a mouse lung cancer model [13], HVEM presents a challenging target due to its context-dependent function as both a stimulatory and inhibitory molecule. Here, TNFRSF14 is linked to lung carcinoma.